Category Archives: Wholesale Pharmacy

5:10 pm Honeywell confident its new automotive refrigerant is safe (HON) : Co said it is confident that SAE International, recognized as the world's leading automotive engineering association, will reconfirm that HFO-1234yf, Honeywell's new low-global-warming-potential automotive air conditioning refrigerant, is safe for use in automobiles. "Based on today's announcement, Honeywell continues to believe that SAE International's latest evaluation will only reconfirm the overwhelming body of data - including rigorous and comprehensive studies conducted in Europe, the U.S. and Japan -- that have clearly and repeatedly determined that HFO-1234yf is safe for use in automobiles," said Dr. Ian Shankland, chief technology officer for Honeywell Performance Materials and Technologies. "HFO-1234yf is a safe and effective refrigerant, and it is better for the environment." 5:03 pm India Globalization Capital receives a listing deficiency letter from the NYSE MKT (IGC) : Co announced that on Tuesday, December 11, 2012, it received a notice from the NYSE MKT LLC stating that the Company is not in compliance with Section 1003(f)(iv) of the Exchange's Company Guide. Specifically the Exchange Staff has determined that the Company has not paid the outstanding listing fees balance for a substantial period of time and, pursuant to Section 1003(f)(iv) of the … Continue reading →

CARLSBAD, Calif., Dec. 11, 2012 /PRNewswire/ --The three best professions for job seekers with disabilities are all in the field of health care: Pharmaceutical Sales, Pharmacy Technician and Physician's Assistant, according to a new report by CareerCast.com. "Organizations specializing in job placement for the disabled find that healthcare employers offer better access to careers than any other industry," says Tony Lee, publisher, CareerCast.com. "Many Americans have some kind of disability and a large percentage of them either work in health care today or will find a job in that sector in the future." The 2010 U.S. Census estimates that 54 million Americans have a disability, which translates into 10% of the population ages 18 to 64. The U.S. Bureau of Labor Statistics reports that unemployment for the disabled is 12.9%, which is significantly higher than the national average and up from a rate of 9.3% at the onset of the recession in 2008. However, healthcare job growth is rising steadily, with the sector expected to increase by 5.6 million jobs within the next eight years, creating many available positions for disabled candidates. Disabled workers can be a great asset to a company, but only about 20% of Americans with a … Continue reading →

DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/dktxnp/china_drug) has announced the addition of the "China Drug Distribution Industry Report, 2012-2015" report to their offering. According to China Drug Distribution Industry Report, 2012-2015 released by Sino Market Insight, the total sales of Chinese drug distribution industry is estimated to surge 102% over 2011 to RMB1.4288 trillion in 2015. In 2011, the sales of Chinese drug distribution industry totalized RMB942.6 billion, attaining a YoY rise of 23% if excluding non-comparable factors. In 2012, the figure will grow 10% YoY to RMB1.0367 trillion. It is expected that the figure will hit RMB1.4288 trillion in 2015, and that Chinese drug retailing industry (including non-medicines) will sustain a CAGR of 11% or so in 2013-2015. In the forthcoming years, drug distribution in China will characterize the followings: The industry growth will accelerate in rural markets. Among the sales of seven major types of pharmaceuticals in 2011, the sales derived from rural areas climbed 27% over the same period of a year earlier (excluding non-comparable factors) to RMB146.1 billion, with the growth rate rising by roughly 4 percentage points. With the development of rural economy and residents' concern about their own health, the pharmaceutical sale in rural areas … Continue reading →

DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/6jf3ch/otc_market_in) has announced the addition of the "OTC Market in Central Europe 2012" report to their offering. Compare OTC markets in six Central European countries Third edition report analyses current conditions and offers forecasts to 2014 Experts on Central European economies have joined together with PMR's most experienced pharmaceutical sector analysts to produce the fifth edition of this comprehensive analysis of the OTC drug and dietary supplement markets in six regional countries: Poland, Romania, the Czech Republic, Hungary, Bulgaria and Slovakia. More than 200 pages in length, this document offers breakdowns of complex market issues and examines historical data, current topics and growth projections. OTC market in Central Europe 2012, Comparative analysis and development forecasts for 2012-2014 offers data, in-depth analysis and accurate forecasts. It provides value estimates for the OTC product segment, coverage of the activities of the leading manufacturers of OTC products and the top selling preparations in each of the six countries included in the scope of the publication. This convenient document offers descriptions of the OTC drug and dietary supplements shares of the overall pharmaceutical markets, as well as market structures prevalent in each country. It offers value data from 2009 … Continue reading →

LIUZHOU, China, Nov. 14, 2012 /PRNewswire/ -- China BCT Pharmacy Group, Inc., (OTC BB: CNBI), ("China BCT" or the "Company"), a leading pharmaceutical distributor, retail pharmacy, and manufacturer of pharmaceutical products in Guangxi Province, China, today announced results for the three and nine month periods ended September 30, 2012. Third Quarter 2012 Highlights "In the third quarter, the trend of strong pressure on wholesale prices and margins continued," said Mr. Huitian Tang, Chief Executive Officer of the Company. "Government pressure on those margins through a zero profit policy for drug sales by the hospitals, a ceiling on drug price increases during the contract bidding process and a mandate for hospitals to take the lowest bid price in all cases continue. These are the challenges that we are addressing. However we have yet to halt the decline in operating profit from our wholesale activities which has declined 32% for the first nine months of the year and 68% for the third quarter. We have put a great deal of effort into expanding our retail operations to offset the wholesale declines and results are encouraging. Our operating profit from our retail activities is up 10% for the year so far, although expansion … Continue reading →

DGAP-News: Celesio AG / Key word(s): Disposal Celesio AG: Celesio sells Irish pharmaceutical wholesale subsidiary to Uniphar 14.11.2012 / 07:00 Celesio sells Irish pharmaceutical wholesale subsidiary to Uniphar * Divestment programme concluded faster than planned Stuttgart, Germany / Dublin, Ireland, 14 November 2012. Celesio sells its Irish pharmaceutical wholesale subsidiary Cahill May Roberts Ltd (including Movianto Ireland) to Uniphar, an Irish pharmaceutical wholesale and logistics company, headquartered in Dublin. The sales price amounts to 49.9 million euro. The transaction is subject to the approval of the relevant bodies. Celesio CEO Markus Pinger: We will now focus on the Irish pharmacy sector. With more than 70 pharmacies we have a strong market position which offers us good growth opportunities.Therefore, the sale of our Irish wholesale subsidiary was a logical consequence. At the same time, we have thus successfully concluded our divestment programme, faster than planned. We will now focus even more on the future growth projects in context with our strategic realignment. In addition to Cahill May Roberts, Celesios divestment programme, which was started in 2012, included the already completed sales of Movianto (excluding Movianto Ireland), Pharmexx, the mail-order pharmacy DocMorris as well as the activities in the Czech Republic. Press … Continue reading →

HANGZHOU, China--(BUSINESS WIRE)-- China Jo-Jo Drugstores, Inc. (CJJD), (the "Company"), a retail and wholesale distributor of pharmaceutical and other healthcare products in Zhejiang and Shanghai, today reported earnings results for the second quarter of fiscal 2013 ended September 30, 2012. The Company will hold its second quarter fiscal 2013 earnings call on Friday, November 16, 2011 at 8:00 a.m. Eastern Time. Please see below for dial in information. Second Quarter Highlights: Dr. Lei Liu, Chairman and CEO, stated, "Given Chinas slower economic and increased regulatory environment towards retail pharmacies, we are pleased that we continue to make progress to better vertically integrate our operations. Our wholesale business has continued to grow and will give us the foothold we need to establish our long-term position." Since August 2011, stricter government policies towards the marketing practices of retail drugstores, industry competition and further government drug price control have impacted sales at our retail drugstores. However, as more of our drugstores are approved to accept government medical insurance, the Company's retail drugstores sales revenue improved to $9,637,418 during the three months ended September 30, 2012 over revenue of $8,393,098 during the three months ended June 30, 2012. Dr. Liu further commented, "Looking forward, … Continue reading →

LIUZHOU, China, Nov. 13, 2012 /PRNewswire/ -- China BCT Pharmacy Group, Inc., (OTC BB: CNBI), ("China BCT" or the "Company"), a leading pharmaceutical distributor, retail pharmacy, and manufacturer of pharmaceutical products in Guangxi Province, China, today announced that it will conduct a conference call at 8:00 a.m. Eastern Time on Wednesday, November 14, 2012 to discuss its third quarter and nine month FY2012 results. Mr. Huitian Tang, Chief Executive Officer of the Company, and Ms. Shelly Zhang, Chief Financial Officer of the Company, will host the conference call. The Company will release its financial results for the third quarter and nine months to September 30, 2012 prior to the call. The conference call can be accessed by dialing 866-759-2078 (U.S. and Canada callers) or 706-643-0585 (international callers) and entering the conference ID 70856824 approximately five to ten minutes prior to the call. A replay will be available for two weeks starting on Wednesday, November 14, 2012 at 11:00 a.m. ET by dialing 855-859-2056 (U.S. and Canada callers) or 404-537-3406 (international callers) and entering the conference replay ID 70856824. About China BCT China BCT is engaged in pharmaceutical distribution, pharmacy retailing, and the manufacture of pharmaceuticals products through its subsidiaries Guangxi … Continue reading →

TALLAHASSEE, Fla. The Florida Department of Business and Professional Regulation (DBPR) today announced that it has reached an agreement with Ameridose, LLC, temporarily halting all shipments from the company to facilities in Florida. Under the agreement, Ameridose will cease all dispensing or wholesale distribution of any products into the state of Florida effective immediately. Ameridoses management is associated with the New England Compounding Center (NECC), the compounding pharmacy linked to the ongoing outbreak of fungal meningitis from contaminated medications. On October 31, 2012, Ameridose issued a voluntary recall of its unexpired products in circulation. Health care professionals should cease using any products from Ameridose at this time and should return the products to the company. Facilities with Ameridose products, which may include hospitals, clinics and other establishments, should contact the company at 888-820-0622 for instructions on how to return the products. A complete list of recalled products subject to this recall is available at http://www.ameridose.com/news/. DBPR is currently working with the Massachusetts Board of Pharmacy to identify facilities in Florida which may have received products from Ameridose. Once these establishments have been identified, DBPR will work with the facilities to ensure that the products have been separated and recall procedures … Continue reading →

SPRINGFIELD, Ill., Nov. 2, 2012 /PRNewswire/ --H. D. Smith, among the nation's largest pharmaceutical wholesalers, today announced that it completed the acquisition of Valley Wholesale Drug. Under the terms of the agreement, Valley Wholesale Drug will be run as a wholly owned subsidiary of H. D. Smith. Day-to-day operations of the subsidiary will be run by Stephen Shoneff, former CEO of Valley, out of the Stockton, California facility. (Logo: http://photos.prnewswire.com/prnh/20121015/NY93014LOGO ) "The close of the acquisition of Valley Wholesale Drug marks a significant step in our strategy to continue growing our national footprint to serve more independent pharmacists across the country especially in the critical market of California, and moving forward, into the Pacific Northwest," said Dale Smith, chairman and chief executive officer, H. D. Smith. "We will continue to focus on exceptional service to our core customers the Retail Independent Pharmacy and we will be well-served to execute on this objective under the leadership of Stephen Shoneff, who has managed the Valley Wholesale Drug business successfully during the last 26 years." About H. D. Smith Headquartered in Springfield, Illinois, H.D.Smith is among the largest national full-line, full-service wholesalersproviding a complete line of pharmaceuticals, OTCs, HBAs, home healthcare products, durable … Continue reading →